Quantivly
Vendor-neutral data and simulation platform for radiology operations using digital twins.
Website: https://quantivly.com/
Cover Block
Public sources
| Field | Value |
|---|---|
| Name | Quantivly |
| Tagline | Vendor-neutral data and simulation platform for radiology operations using digital twins |
| Headquarters | Boston, United States |
| Founded | 2019 |
| Stage | Seed |
| Business Model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Academic Spinout |
| Funding Label | Seed |
| Total Disclosed Funding | ~$6,100,000 [medicalstartups.org] |
Links
Public sources
- Website: https://quantivly.com/
- LinkedIn: https://www.linkedin.com/company/quantivly
Executive Summary
PUBLIC Quantivly builds vendor-neutral software for radiology operations, and it merits investor attention because it is trying to turn fragmented imaging workflow data into a simulation layer that hospital imaging leaders can use to improve capacity, quality, and scheduling, a narrower and more operational wedge than most AI narratives in medical imaging [quantivly.com] [150sec, June 2025] [quantivly.com, November 2023]. The company traces its origins to work by Benoit Scherrer and Robert MacDougall at Boston Children’s Hospital, where they reportedly developed an earlier MRI metadata prototype before spinning out Quantivly in 2019 and commercializing the platform in 2022 [150sec, June 2025] [LinkedIn, January 2026].
The product case rests on data infrastructure first: Quantivly says it extracts and harmonizes data from imaging systems, RIS, and PACS, then uses a "Digital Twin" to let radiology operators inspect workflows, compare scheduled versus actual events, detect protocol deviations, and test operational changes in software before making them in practice [quantivly.com] [quantivly.com, November 2023] [quantivly.com, December 2022]. That positioning matters because the company is centered on radiology operations rather than image interpretation, which may put it closer to budget owners focused on throughput, staffing, and access than to the crowded clinical AI market [quantivly.com, November 2023] [150sec, June 2025].
The founding team looks credible for the problem set on public record. Scherrer is identified by the company and external coverage as a Harvard Medical School radiology faculty member with prior Boston Children's Hospital experience, while MacDougall is described as a former director of diagnostic imaging physics at Boston Children's Hospital, giving the pair domain depth in both imaging science and operational workflow [150sec, June 2025] [medicalstartups.org] [Google Scholar].
On financing, public sources point to a seed-stage company with disclosed funding of about $6.1 million, including a $1.7 million pre-seed in 2022 and a $3 million seed round in 2023, alongside NSF support, although source quality here is mixed and totals are not perfectly reconciled across databases [medicalstartups.org] [Crunchbase] [150sec, June 2025]. com] [LinkedIn, January 2026] [quantivly.com, November 2023].
Lightly corroborated -- Section uses a mix of company materials and limited third-party corroboration, with stronger support on founding story and product framing than on funding totals and commercial traction.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Seed |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Academic Spinout |
| Funding | Total disclosed about $6.1 million |
How the Company Got Here
PUBLIC
Quantivly presents as a Boston-based radiology operations software company, with public materials describing a vendor-neutral platform built to organize and analyze imaging operations data rather than interpret scans clinically [quantivly.com]. Crunchbase lists the company as founded in 2019 and headquartered in Boston, Massachusetts [Crunchbase]. The company’s own site says it spun out of Boston Children’s Hospital, which is the clearest public statement of origin available in the cited record [quantivly.com].
The chronology that can be supported from public sources is narrow but useful. Crunchbase records the company’s formation in 2019 [Crunchbase]. Company-published materials then show Quantivly speaking publicly about its radiology operations "digital twin" concept by December 2022, when co-founder Robert MacDougall discussed the company’s vision in an interview posted by Quantivly [quantivly.com, December 2022]. By November 2023, the company was describing its product more concretely as a system for simulating radiology operations through digital twins and harmonized operational data [quantivly.com, November 2023].
The public record does not establish a legal entity name or disclose much corporate infrastructure beyond those basics. What it does show, consistently, is a company formed around imaging operations workflow data, rooted in Boston, and tracing its early development to Boston Children’s Hospital before moving into commercial positioning under the Quantivly brand [quantivly.com] [Crunchbase].
Lightly corroborated -- Founded year and headquarters are corroborated by Crunchbase and the company website, but the spinout history and milestone detail are primarily company-sourced.
Product and Technology
MIXED
The product story is narrower, and more interesting, than a generic healthcare AI pitch. Quantivly is described publicly as a vendor-neutral data and simulation platform for radiology operations, with its software focused on operational data rather than clinical diagnosis [quantivly.com] [150sec, June 2025]. In the company’s materials, the core job is to extract and harmonize data from imaging systems and workflow software into a unified operational layer, including MRI, CT, PET, RIS, and PACS environments [quantivly.com] [quantivly.com, November 2023].
From there, the company presents a "Digital Twin" layer for radiology operations. Public product pages say users can review protocols and imaging parameters, detect protocol deviations, and measure quality, scan duration, and repeat rates; documentation snippets also point to timeline views that let operators inspect scheduled versus actual events at the scanner level [quantivly.com] [quantivly.com, Unknown]. Press and interview material describe the same system as a way to observe, measure, simulate, and optimize imaging operations before making real-world workflow changes, which fits the company’s repeated framing around capacity, staffing, and patient access rather than diagnostic output [quantivly.com, December 2022] [quantivly.com, November 2023] [150sec, June 2025].
What is visible publicly suggests the technical differentiation rests on data normalization and workflow modeling, not on a novel model layer disclosed in detail. Quantivly and affiliated commentary describe a unified data layer or ontology built on radiology workflow data, with references to DICOM and HL7 harmonization and a vendor-agnostic description of imaging exams, but those claims are still lightly corroborated outside company-controlled channels [quantivly.com, Unknown] [LinkedIn] [LinkedIn, January 2026]. There is also a lightweight hiring signal: the careers page says the company is looking for engineers interested in digital twins and AI in healthcare, though it does not expose enough detail to support a credible public read on stack choices (inferred from job postings) [quantivly.com].
Company-stated, unverified -- This section relies primarily on company website materials and company-published interviews, with limited external corroboration from 150sec and LinkedIn.
Where the Demand Sits
Market context
PUBLIC The market matters because radiology departments are being asked to do more with aging infrastructure, fragmented data, and persistent access bottlenecks, which makes operational software easier to underwrite than many diagnosis-first imaging bets [quantivly.com, Unknown] [150sec, June 2025].
Quantivly is positioned at the intersection of imaging informatics, hospital operations software, and workflow analytics, rather than image interpretation itself [quantivly.com, Unknown] [quantivly.com, November 2023]. That distinction matters for market framing. The company is selling into a part of healthcare IT where budget authority can sit with radiology administrators, imaging operations leaders, and health systems trying to improve throughput, staffing efficiency, protocol compliance, and scanner utilization, according to the company and interview material featuring the founders [quantivly.com, Unknown] [quantivly.com, December 2022] [150sec, June 2025].
No named third-party market report with a defensible TAM, SAM, or SOM for Quantivly's exact category appears in the provided evidence, so any sizing here has to stay qualitative. The closest adjacent categories are radiology workflow software, imaging informatics, and hospital operations analytics, but the source set does not contain confirmed third-party market values for those segments. That leaves the practical market definition narrower than broad medical imaging software and closer to operational intelligence for MRI, CT, PET, RIS, PACS, and scheduling environments that still run on heterogeneous systems [quantivly.com, Unknown] [quantivly.com, November 2023].
Demand drivers and adjacent markets
PUBLIC Demand appears to be driven less by new scanner purchases and more by the need to extract usable operational data from installed imaging estates [quantivly.com, Unknown] [150sec, June 2025].
The clearest tailwind in the source set is operational complexity. Quantivly's core pitch starts from the claim that imaging providers sit on fragmented scanner, workflow, RIS, and PACS data that is difficult to query or compare across systems, and that a unified data layer can support better decisions on capacity, quality, duration, repeat rates, staffing, and access [quantivly.com, Unknown] [quantivly.com, Unknown] [quantivly.com, November 2023]. If that pain point is real at the department level, the spend case is tied to throughput and labor productivity rather than discretionary innovation budgets, which generally makes procurement logic more durable.
A second tailwind is that the product sits adjacent to, but does not depend on, clinical AI adoption. Quantivly's public materials and founder interviews consistently describe the software as radiology operations infrastructure, with digital twins used to test "what if" interventions in software before changing real workflows [quantivly.com, November 2023] [quantivly.com, December 2022]. That places the company beside, rather than directly against, image-reading algorithms and computer-aided diagnosis tools. In practice, the adjacent and substitute markets include scheduling software, business intelligence dashboards, radiology quality tools, PACS and RIS analytics modules, and broader hospital operations platforms.
Sizing evidence available from public sources
PUBLIC The public evidence is stronger on category shape than on category size, so the most useful market table here is a boundaries table rather than a fabricated TAM model.
| Market frame | What the sources support | Source basis |
|---|---|---|
| Core target market | Radiology operations software for hospitals, imaging centers, and radiology departments using MRI, CT, PET, RIS, and PACS data | [quantivly.com, Unknown] [quantivly.com, November 2023] |
| Adjacent market | Imaging informatics and workflow analytics tied to scanner utilization, protocol management, quality, and access | [quantivly.com, Unknown] [150sec, June 2025] |
| Substitute budget lines | Native analytics in RIS/PACS, general hospital BI tools, scheduling software, and operational consulting | [quantivly.com, Unknown] [quantivly.com, December 2022] |
| Expansion vector | Data infrastructure for automation or agentic orchestration layered on top of operational ontology | [LinkedIn, Unknown] [LinkedIn, Unknown] |
The table shows a category that is legible, but still emerging. The near-term spend case rests on workflow and capacity software, while the longer-term upside depends on whether a unified imaging operations layer becomes a system of record for automation rather than a reporting overlay [150sec, June 2025] [LinkedIn, Unknown].
Regulatory and macro forces
PUBLIC The external environment is supportive in a narrow, practical way: hospitals are under pressure to improve access and efficiency, but healthcare procurement still favors tools that fit existing workflows and data standards [150sec, June 2025] [quantivly.com, Unknown].
Two forces stand out in the source set. First, Quantivly's ontology-driven approach is built around established imaging and health data formats such as DICOM and HL7, which suggests the company is trying to work with incumbent infrastructure rather than asking departments to rip and replace core systems [LinkedIn, Unknown]. Second, the emphasis on operations over diagnosis may reduce some of the regulatory exposure that attaches to software making clinical claims, though the provided sources do not include a formal regulatory classification and no such conclusion should be overstated.
The macro risk is that hospital software budgets remain slow-moving and integration-heavy. Even if the problem is clear, adoption can still be gated by interoperability work, stakeholder alignment across radiology and IT, and proof that the software changes measurable operational outcomes rather than simply surfacing dashboards. The market is therefore attractive where pain is measurable, but it is unlikely to behave like a fast-cycle horizontal SaaS category [quantivly.com, November 2023] [150sec, June 2025].
Lightly corroborated -- Market shape and demand drivers are supported by company materials and one independent profile, but no confirmed third-party market sizing report was available in the cited public evidence.
Competitive Landscape
Market structure
MIXED Quantivly is positioned less as a diagnostic AI vendor and more as an operating system layer for radiology departments that need to make scanner, protocol, scheduling, and workflow data usable across fragmented imaging environments [quantivly.com] [quantivly.com, November 2023] [150sec, June 2025].
That puts the company in a somewhat unusual lane. The closest alternatives visible in public materials are not a named set of direct startup peers in the source pack, but three broader groups: incumbent imaging IT systems such as RIS, PACS, and modality software that already hold pieces of workflow data; radiology workflow and orchestration tools that can improve scheduling or throughput without first building a unified data model; and services-led internal analytics efforts inside hospital systems that stitch together DICOM, HL7, and scheduling data for local operational reporting [quantivly.com] [quantivly.com, November 2023]. Quantivly's own messaging argues that the operational problem sits in the fragmentation itself, which is why it emphasizes vendor neutrality and a harmonized ontology rather than a single-point application feature [quantivly.com] [quantivly.com, Unknown].
A separate adjacent category comes from AI marketplaces and workflow platforms in imaging, including listings such as Quantivly Hub on Blackford's site, which suggests that some buyers may encounter the product through broader imaging software distribution layers rather than through a stand-alone analytics purchase [blackfordanalysis.com]. That matters because it implies competition for budget can come from adjacent workflow platforms even when the product category is framed differently. In practice, a radiology leader may compare Quantivly not only against another digital twin concept, but against any tool that promises faster scheduling decisions, protocol standardization, or capacity gains with less implementation work [blackfordanalysis.com] [quantivly.com].
The current edge, to the extent public evidence supports one, appears to be technical specificity and founder-market fit. Quantivly says it built a unified data layer for imaging operations and tied it to digital twin simulations, while public profiles place both founders inside Boston Children's Hospital radiology before the 2019 spinout [quantivly.com] [LinkedIn, January 2026] [150sec, June 2025]. That combination can matter in enterprise health software because the hard part is often not dashboarding but normalizing machine, protocol, and workflow data into something operations leaders can trust. The same edge is also perishable. If the ontology is difficult to replicate, durability rises; if buyers instead value packaged workflow applications, channel access, or incumbent integrations more than the underlying data model, larger imaging IT vendors or marketplace distributors could narrow the gap quickly [quantivly.com] [blackfordanalysis.com].
Exposure and likely near-term dynamics
MIXED The clearest exposure is distribution. Public sources describe the product vision in some detail, but they do not identify named health-system customers at scale, disclosed commercial partnerships beyond marketplace-style visibility, or a broad installed base that would force competitors to route around Quantivly [150sec, June 2025] [blackfordanalysis.com]. In health systems, incumbent vendors that already sit inside RIS, PACS, scheduling, or modality workflows may hold the commercial advantage even if their data model is less elegant, because procurement often follows existing integrations, security reviews, and budget owners rather than architectural purity [quantivly.com] [blackfordanalysis.com].
The company is also exposed to adjacent tools that solve narrower problems with a shorter sales cycle. If a radiology department mainly wants protocol compliance monitoring, scanner timeline visibility, or repeat-rate measurement, Quantivly can address those use cases according to its site, but buyers may still prefer a simpler point solution or an enhancement from an existing vendor if the digital twin layer feels like future value rather than immediate necessity [quantivly.com]. That does not weaken the thesis, but it does shape the go-to-market burden: the company has to prove that a unified operational layer compounds value across several workflows, not just one [quantivly.com, December 2022] [quantivly.com, November 2023].
The most plausible 18-month scenario is a split market in which the winner depends on whether radiology buyers prioritize deep operational interoperability or procurement convenience. Quantivly is the likely winner if imaging providers increasingly treat fragmented operational data as the bottleneck and are willing to adopt a vendor-neutral layer first, because that aligns directly with its public product narrative and founder background [quantivly.com] [150sec, June 2025]. Quantivly is the likely loser if incumbent workflow and imaging IT vendors satisfy most demand through bundled analytics and existing channels, because the company does not appear from public evidence to own the primary system of record or the dominant commercial channel today [blackfordanalysis.com] [150sec, June 2025].
Lightly corroborated -- Competitive interpretation is grounded in company materials, a named profile in 150sec, and Blackford marketplace evidence, but the source set does not identify named direct competitors or independently verified customer-scale comparisons.
Opportunity
Upside case
PUBLIC The prize here is unusually large for a seed-stage imaging software company, because a system that becomes the operational data layer for radiology could sit upstream of scheduling, staffing, scanner utilization, protocol quality, and eventually automation across a high-cost hospital function [quantivly.com, Unknown] [quantivly.com, November 2023] [150sec, June 2025].
The headline opportunity is not a better dashboard. It is the chance to become the default operating layer for imaging operations, first inside radiology departments and then across broader diagnostic networks. That outcome is at least reachable on the public record because Quantivly is positioned around a vendor-neutral ontology that pulls together data from scanners, RIS, PACS, and workflow systems, and then applies simulation through a digital twin rather than stopping at static reporting [quantivly.com, Unknown] [quantivly.com, November 2023] [blackfordanalysis.com, Unknown]. If that layer is genuinely hard to replicate, and the company can prove it inside live hospital workflows, the product could matter to buyers as infrastructure rather than point software [150sec, June 2025] [quantivly.com, December 2022].
A second reason the upside is real rather than purely conceptual is founder-market fit. Benoit Scherrer and Robert MacDougall came out of Boston Children's Hospital, where the early prototype work reportedly began, and the company describes itself as a 2019 spinout that commercialized in 2022 [LinkedIn, January 2026] [150sec, June 2025] [quantivly.com, Unknown]. In healthcare infrastructure, especially in imaging, that domain specificity matters because integration and workflow credibility often determine whether a product reaches operational ownership or stays trapped in pilot mode [quantivly.com, November 2023].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Radiology system of record | Quantivly becomes the operational source of truth for MRI, CT, PET, scheduling, and protocol performance across health systems | A reference deployment proves measurable gains in capacity, repeat-rate reduction, or protocol compliance, then expands scanner by scanner within the same enterprise | The product is already described as vendor-neutral and built to harmonize heterogeneous imaging data into a unified layer, which is the prerequisite for system-of-record status [quantivly.com, Unknown] [quantivly.com, November 2023] |
| Simulation layer for capacity expansion | The digital twin becomes the planning tool hospitals use before changing staffing, schedules, or scanner allocation | Buyers shift from descriptive analytics to in-software simulation of operational changes, especially as imaging access remains constrained | Quantivly publicly frames the product around observing, measuring, simulating, and optimizing operations before real-world changes are made [quantivly.com, November 2023] [quantivly.com, Unknown] |
| Data backbone for imaging automation | Quantivly's ontology becomes the substrate on which automation and agentic workflows are built for scheduling, reimbursement capture, and quality management | A product release or partner integration moves the company from visibility into limited execution and orchestration | Public statements from company and adjacent operator commentary both point to a data-and-automation architecture, with the data layer described as the difficult technical foundation [150sec, June 2025] [LinkedIn] [quantivly.com, Unknown] |
The compounding dynamic, if it appears, is a classic infrastructure flywheel. One scanner or modality integration creates normalized data; normalized data supports more credible benchmarking and simulation; better operational recommendations make the software harder to remove; and each additional site or workflow should improve the company's ontology and implementation playbook [quantivly.com, Unknown] [quantivly.com, November 2023]. In public materials, Quantivly already emphasizes protocol-level visibility, timeline inspection, and vendor-agnostic data harmonization, which suggests the company is trying to own the underlying data model rather than a single application surface [quantivly.com, Unknown] [blackfordanalysis.com, Unknown]. That matters because in hospital software, the stickiest asset is often the cleaned and contextualized operational dataset sitting between legacy systems and frontline decisions.
The size of the win is harder to quantify cleanly from the available evidence, because no verified public market sizing or close public comparable was captured in the source set. Even so, a reasonable upside framing is that if Quantivly becomes the default operational layer for imaging networks, the company would look less like a narrow radiology analytics vendor and more like specialized healthcare infrastructure with multiple software surfaces built on top of the same ontology [quantivly.com, Unknown] [150sec, June 2025]. What that could be worth is best expressed qualitatively here: a successful infrastructure position in a regulated, high-workflow-intensity category can support a meaningfully larger outcome than a single-use analytics tool (scenario, not a forecast). The public evidence supports that possibility, but not a precise valuation bridge.
Company-stated, unverified -- This section relies heavily on company materials and limited third-party coverage, with no confirmed public market-size dataset or independently verified customer outcomes in the cited evidence.
Sources
Public sources
[medicalstartups.org] Quantivly (USA) Funding: $6.1M | https://www.medicalstartups.org/startup/quantivly/
[150sec, June 2025] The French Harvard academic using AI to upend medical imaging. | https://www.150sec.com/the-french-harvard-academic-using-ai-to-upend-medical-imaging/20301/amp
[quantivly.com, November 2023] Quantivly on SmartHealth Podcast: Simulating Radiology Operations via Digital Twins | https://quantivly.com/quantivly-on-smarthealth-podcast-simulating-radiology-operations-via-digital-twins/
[LinkedIn, January 2026] Quantivly’s Origin Story with Robert MacDougall at RSNA2025 | https://www.linkedin.com/posts/quantivly_rsna2025-ai-imagingops-activity-7418751588061716481-k5Sa
[quantivly.com] Home - Quantivly | https://quantivly.com/
[quantivly.com, December 2022] Quantivly’s co-founder interviewed by Casey Insights | https://quantivly.com/bobby-interviewed-by-casey-insights/
[Google Scholar] Benoit Scherrer - Google Scholar | https://scholar.google.com/citations?user=XKJodHcAAAAJ&hl=fr
[Crunchbase] Quantivly - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/quantivly
[LinkedIn] Quantivly | LinkedIn | https://www.linkedin.com/company/quantivly
[blackfordanalysis.com] End-to-end imaging workflow. | Quantivly Hub | https://blackfordanalysis.com/ai-portfolio-quantivly-hub
Articles about Quantivly
- Quantivly's Digital Twin Simulates the Radiology Department Before a Patient Arrives — A Boston spinout from Harvard and Boston Children's Hospital is using its novel ontology to model scanner capacity, staffing, and patient flow.